Table 1.
Cell type/model | Mycobacterial strain/ Mtb protein | MOI | Incubation post-infection | Impact on mitochondrial structure | Immunological consequence | Impact on non-mitochondrial bioenergetics | Impact on mitochondrial bioenergetics | Impact on cell fate | References | |
---|---|---|---|---|---|---|---|---|---|---|
Human | THP-1 | Mtb H37Rv | 10 5 |
24 h 24 h |
Increased electron density, with a clear and vivid definition of the cristae | Modest increase in TNF-α | Increased as compared to uninfected cells | Mitochondrial membrane transition potential was significantly increased than H37Ra Increase in this ATP/ADP ratio augments activity of the mitochondrial electron transport chain Decreased ATP (mitochondrial respiration) Oxygen consumption rate as in basal respiration, total respiration, proton leak, and TCA are all reduced as compared to uninfected THP-1 |
Modest increase in both apoptosis and necrosis | (Riendeau and Kornfeld, 2003; Jamwal et al., 2013; Asalla et al., 2017; Cumming et al., 2018) |
Dead Mtb | 5 | 24 h | Slightly reduced as compared to untreated cells | Oxygen consumption rate as in basal respiration, total respiration, proton leak, and TCA are reduced slightly as compared to uninfected THP-1 but much higher than Mtb or BCG | No effect | (Cumming et al., 2018) | ||||
Mtb H37Ra | 10 | 24 h | A significant reduction in the electron density of the matrix outlines of the cristae were distinct and there was no gross pathology of the mitochondria | TNF-α | Mitochondrial membrane potential was significantly lower than H37Rv Decrease in this ATP/ADP ratio as compared to uninfected cells Decreased mitochondrial electron transport chain |
Apoptosis | (Jamwal et al., 2013) | |||
BCG | 10 5 1 |
24 h 2-72 h |
Significant increase in TNF-α Significant release of CCL2 Activates macrophages |
Non-mitochondrial respiration is more than that induced by Mtb | Generates superoxide radicals Oxygen consumption rate as in basal respiration, total respiration, proton leak, and TCA are all reduced as compared to uninfected THP-1but higher than Mtb |
Significant increase in apoptosis | (Riendeau and Kornfeld, 2003; Méndez-Samperio et al., 2010; Chávez-Galán et al., 2016; Asalla et al., 2017; Cumming et al., 2018) | |||
U937 |
Mtb H37Rv Mtb H37Ra |
10 10 |
1–5 days 1–5 days |
ΔMMP increased greater with H37Rv than H37Ra but similarly with MOI > 5 | Modest increase in apoptosis and necrosis (day3 onwards) Significant increase in apoptosis and not necrosis (day3 onwards) |
(Danelishvili et al., 2003) | ||||
Jurkat T cells | rRv1818c-Tat | 1–15 μg/ml | 24 h | Rv1818c localizes to mitochondria | Caspase dependent apoptosis | (Balaji et al., 2007) | ||||
RD (sarcoma) | Transient expression of PE_PGRS33 | 1 μg plasmid with Lipofectamine | 24 h | PE_PGRS33 localizes to mitochondria | Apoptosis (24 h onwards) and necrosis (late stage-48 h onwards) | (Cadieux et al., 2011) | ||||
PBMC derived macrophages |
Mtb H37Rv Mtb H37Ra LpqH |
2–10 2–10 0.5–50 μg/ml |
0–48 h 0–48 h 24 h |
At MOI = 5, H37Rv caused more MMP and cytC release at 6 h At MOI-10, both H37Rv and H37Ra caused an equal release of cytC and back at 48 h |
Modest increase in apoptosis 48 h and necrosis(72 h) Significant increase in apoptosis and modest increase in necrosis Caspase dependent apoptosis |
(Chen et al., 2006; Sánchez et al., 2012) | ||||
PBMC derived dendritic cells |
Mtb H37Rv Mtb H37Ra Dead Mtb |
1–10 1–10 1–10 |
24–48 h 24–48 h 24–48 h |
DC maturation Il-1, Il-6, TNF-α. DC maturation Il-1, Il-6, TNF- α No DC maturation IL-6, IL-8, TNF- α secreted |
Non-apoptotic cell death Non-apoptotic cell death No cell death |
Caspase independent | (Ryan et al., 2011) | |||
alveolar epithelial cells (A549 type II epithelial cells) |
Mtb Erdman Mtb CDC1551 M. bovis-BCG Mtb Erdman, an ESAT-6 deletion mutant M. smegmatis |
10, 100 10 10, 100 50 |
6–24 h 48 h 6–48 h 6–24 h 48 h |
No effect Fragmented, appear as spherical structures Decrease in mitochondrial mass (pronounced effect with MOI = 100) No effect on mitochondrial structure and mass No effect |
No inflammasome activation | No effect No effect Significant decrease in MMP |
Necrosis (post 48 h) Necrosis Necrosis (post 5 days) No cytotoxicity up to MOI = 50 |
(Dobos et al., 2000; Fine-Coulson et al., 2015) | ||
Murine | macrophage cell line RAW 264.7 | H37Rv rRv3261 rHBHA BCG |
10–20 10 μg/ml 10 |
1–4 days 24 h 24 h |
Localizes to mitochondria | Dose dependent LDH release ROS production TNF, IL-6, MCP-1 TNF-α and IL-6 are secreted |
Loss of membrane potential, Bax translocation, Cyt C release Decrease in MMP, bax translocation, Cyt C release Decrease in MMP |
Necrosis in a dose and time-dependent manner Caspase-3/9 dependent apoptosis Caspase dependent apoptosis Caspase dependent apoptosis |
(Sohn et al., 2011; Wu et al., 2014; Jee et al., 2017; Lee et al., 2020) |
The above list includes a diverse array of cell types used in mycobacterial research with details of variables of experimental conditions (Specific strain, MOI, incubation time post-infection) with mitochondria-associated readouts such as morphological changes, Bioenergetic changes, and cell fate. It is be noted that it is not an exhaustive list of all model cell types and mycobacterial strains used in mycobacterial research.